Skip to Main Content

Paper Details

The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results.
Mayo Clin Proc
29
2018
68 genes, CVD, CVD genes, FH, FH CVD, FH CVD genes, P/LP, P/LP variants, PATIENTS, cardiovascular disease, cardiovascular disease (CVD) genes, colon polyps, disease-related genes, hyperlipidemia, non-, non-familial hypercholesterolemia, participants
Cardiovascular Diseases, Cohort Studies, Colon, Female, Genetic Predisposition to Disease, Genetic Testing, Genomics, Humans, Hyperlipidemias, Male, Middle Aged, Outcome Assessment, Health Care, Phenotype, Polymorphism, Single Nucleotide, Polyps, Surveys and Questionnaires
Author NameAffiliation
Iftikhar J KulloMayo Clinic
Janet E OlsonBiomedical Ethics Program, Mayo Clinic
Xiao FanMayo Clinic
Merin JoseMayo Clinic
Maya S SafarovaMayo Clinic
Carmen Radecki BreitkopfBiomedical Ethics Program, Mayo Clinic
Erin M WinklerCenter for Individualized Medicine-Genomics, Mayo Clinic
David C KochanMayo Clinic
Sara SnipesMayo Clinic
Joel E PacynaBiomedical Ethics Program, Mayo Clinic
Meaghan CarneyMayo Clinic
Christopher G ChuteJohns Hopkins University
Jyoti GuptaNational Human Genome Research Institute
Sheethal JoseNational Human Genome Research Institute
Eric VennerBaylor College of Medicine Human Genome Sequencing Center
Mullai MuruganBaylor College of Medicine Human Genome Sequencing Center
Yunyun JiangBaylor College of Medicine Human Genome Sequencing Center
Magdi ZordokMayo Clinic
Medhat FarwatiMayo Clinic
Maraisha PhilogeneMayo Clinic
Erica SmithMayo Clinic
Gabriel Q ShaibiCenter for Health Promotion and Disease Prevention, Arizona State University
Pedro J CaraballoMayo Clinic
Robert R FreimuthBiomedical Ethics Program, Mayo Clinic
Noralane M LindorMayo Clinic
Noralane M LindorMayo Clinic
Richard R SharpBiomedical Ethics Program, Mayo Clinic
Stephen N ThibodeauMayo Clinic
  • 1 - 28

Datasets

Release 1.2